OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Earnings Per Share (EPS) History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-4.75 | ₹-2.78 | ₹-1.04 | ₹-8.15 | ₹-0.43 |
What is the latest Earnings Per Share (EPS) of OXYGENTA PHARMACEUTICAL ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹-4.75 |
| Mar2025 | ₹-2.78 |
| Mar2024 | ₹-1.04 |
| Mar2023 | ₹-8.15 |
| Mar2022 | ₹-0.43 |
How is Earnings Per Share (EPS) of OXYGENTA PHARMACEUTICAL Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹-4.75 | Negative | |
| Mar2025 | ₹-2.78 | Negative | |
| Mar2024 | ₹-1.04 | Negative | |
| Mar2023 | ₹-8.15 | Negative | |
| Mar2022 | ₹-0.43 | - | |
Compare Earnings Per Share (EPS) of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹185.2 Cr | -3.9% | 5.2% | -55.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -3.9% |
5.2% |
-55.4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses